| Pharmasia8 Limited |
| Registered number: |
07998080 |
| Balance Sheet |
| as at 31 May 2023 |
|
| Notes |
|
|
2023 |
|
|
2022 |
| £ |
£ |
| Fixed assets |
| Intangible assets |
3 |
|
|
648,916 |
|
|
648,916 |
| Investments |
5 |
|
|
100 |
|
|
100 |
|
|
|
|
649,016 |
|
|
649,016 |
|
| Current assets |
| Stocks |
|
|
27,618 |
|
|
21,149 |
| Debtors |
6 |
|
178,141 |
|
|
164,929 |
| Cash at bank and in hand |
|
|
1,204,585 |
|
|
807,678 |
|
|
|
1,410,344 |
|
|
993,756 |
|
| Creditors: amounts falling due within one year |
7 |
|
(319,441) |
|
|
(421,666) |
|
| Net current assets |
|
|
|
1,090,903 |
|
|
572,090 |
|
| Total assets less current liabilities |
|
|
|
1,739,919 |
|
|
1,221,106 |
|
| Creditors: amounts falling due after more than one year |
8 |
|
|
(440,100) |
|
|
(440,100) |
|
|
| Net assets |
|
|
|
1,299,819 |
|
|
781,006 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
1,299,719 |
|
|
780,906 |
|
| Shareholders' funds |
|
|
|
1,299,819 |
|
|
781,006 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
| Mr Hiran Patel |
| Director |
| Approved by the board on 17 August 2023 |
|
| Pharmasia8 Limited |
| Notes to the Accounts |
| for the year ended 31 May 2023 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Goodwlll/Retail Pharmacy Licences |
|
Goodwill arising on acquisition of business is capitalised and is subject to an annual impairment review by the directors in accordance with FRS 10. The directors consider that the goodwill, which includes the cost of retail pharmacy licences, has an indefinite life and is therefore not amortised. Based upon their open market valuations of goodwill, any material diminution in value compared to the carrying amount in the financial statements has been written off to the profit and loss account.
The directors believe that the right for dispensing UK NHS prescriptions, being the pharmacy licence which is attached to a particular pharmacy, has a continuing value. Such rights, conferred by the Department of Health as contracts to dispense prescriptions, are not generally granted to new pharmacies in the same locality. Any deficiency arising from the impairment review is written off to the profit and loss account in the year in which it arises. Any increases in value are not recognised in the financial statements.
The departure from the requirements of the Companies Act 1985, is in the opinion of the
directors, necessary for the financial statements to give a true and fair view. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Plant, machinery, fixtures & fittings & cars |
100% straight line |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
|
Pensions |
|
Contributions to defined contribution plans are expensed in the period to which they relate. |
|
|
| 2 |
Employees |
2023 |
|
2022 |
| Number |
Number |
|
|
Average number of persons employed by the company |
7 |
|
7 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Intangible fixed assets |
£ |
|
Goodwill: |
|
|
Cost |
|
At 1 June 2022 |
648,916 |
|
At 31 May 2023 |
648,916 |
|
|
|
|
|
|
|
|
|
|
Amortisation |
|
At 31 May 2023 |
- |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 May 2023 |
648,916 |
|
At 31 May 2022 |
648,916 |
|
|
|
|
|
|
|
|
|
|
Goodwill is subject to an impairment review (see accounting policy note). |
|
|
| 4 |
Tangible fixed assets |
|
|
Land and buildings |
|
Plant and machinery etc |
|
Motor vehicles |
|
Total |
| £ |
£ |
£ |
£ |
|
Cost |
|
At 1 June 2022 |
2,326 |
|
81,113 |
|
79,340 |
|
162,779 |
|
Additions |
- |
|
2,801 |
|
63,945 |
|
66,746 |
|
Disposals |
- |
|
- |
|
(22,990) |
|
(22,990) |
|
At 31 May 2023 |
2,326 |
|
83,914 |
|
120,295 |
|
206,535 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 June 2022 |
2,326 |
|
81,113 |
|
79,340 |
|
162,779 |
|
Charge for the year |
- |
|
2,801 |
|
63,945 |
|
66,746 |
|
On disposals |
- |
|
- |
|
(22,990) |
|
(22,990) |
|
At 31 May 2023 |
2,326 |
|
83,914 |
|
120,295 |
|
206,535 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 May 2023 |
- |
|
- |
|
- |
|
- |
|
|
| 5 |
Investments |
|
| Other |
| investments |
| £ |
|
Cost |
|
At 1 June 2022 |
100 |
|
|
At 31 May 2023 |
100 |
|
|
| 6 |
Debtors |
2023 |
|
2022 |
| £ |
£ |
|
|
Trade debtors |
178,141 |
|
164,929 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Creditors: amounts falling due within one year |
2023 |
|
2022 |
| £ |
£ |
|
|
Trade creditors |
177,982 |
|
234,707 |
|
Taxation and social security costs |
54,648 |
|
123,791 |
|
Other creditors |
86,811 |
|
63,168 |
|
|
|
|
|
|
319,441 |
|
421,666 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Creditors: amounts falling due after one year |
2023 |
|
2022 |
| £ |
£ |
|
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
|
100 |
|
100 |
|
Other creditors-directors loan |
440,000 |
|
440,000 |
|
|
|
|
|
|
440,100 |
|
440,100 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Other financial commitments |
2023 |
|
2022 |
| £ |
£ |
|
|
Total future minimum payments under non-cancellable operating leases |
|
34,000 |
|
45,000 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Related party transactions |
|
|
Loan due to directors at year end was £440,000 (2022-£440,000) and it is reflected as due after one year and on which interest is payable at 10% per annum £44,000 (2022-£44,000) and £80,010 (2022-£57,618) interest free and it is reflected as due within one year under creditors. |
|
|
| 11 |
Controlling party |
|
|
The ultimate controlling party is Hiran and Bhavna Patel in view of them holding 100% shares in the company. |
|
|
| 12 |
Other information |
|
|
Pharmasia8 Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
195 Bramley Road |
|
London |
|
N14 4XA |
